These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 24819957)

  • 21. The design of naproxen solid lipid nanoparticles to target skin layers.
    Akbari J; Saeedi M; Morteza-Semnani K; Rostamkalaei SS; Asadi M; Asare-Addo K; Nokhodchi A
    Colloids Surf B Biointerfaces; 2016 Sep; 145():626-633. PubMed ID: 27288817
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Part I: Development and optimization of solid-lipid nanoparticles using Box-Behnken statistical design for ocular delivery of gatifloxacin.
    Abul Kalam M; Sultana Y; Ali A; Aqil M; Mishra AK; Aljuffali IA; Alshamsan A
    J Biomed Mater Res A; 2013 Jun; 101(6):1813-27. PubMed ID: 23255511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improved uptake and bioavailability of cinnamaldehyde
    Wu L; Meng Y; Xu Y; Chu X
    Pharm Dev Technol; 2022 Dec; 27(10):1038-1048. PubMed ID: 36367964
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microwave-assisted microemulsion technique for production of miconazole nitrate- and econazole nitrate-loaded solid lipid nanoparticles.
    Shah RM; Eldridge DS; Palombo EA; Harding IH
    Eur J Pharm Biopharm; 2017 Aug; 117():141-150. PubMed ID: 28411057
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preparation and characterization of ibuprofen solid lipid nanoparticles with enhanced solubility.
    Potta SG; Minemi S; Nukala RK; Peinado C; Lamprou DA; Urquhart A; Douroumis D
    J Microencapsul; 2011; 28(1):74-81. PubMed ID: 21171818
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comet assay reveals no genotoxicity risk of cationic solid lipid nanoparticles.
    Doktorovova S; Silva AM; Gaivão I; Souto EB; Teixeira JP; Martins-Lopes P
    J Appl Toxicol; 2014 Apr; 34(4):395-403. PubMed ID: 24243595
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of solid lipid nanoparticles for enhanced solubility of poorly soluble drugs.
    Potta SG; Minemi S; Nukala RK; Peinado C; Lamprou DA; Urquhart A; Douroumis D
    J Biomed Nanotechnol; 2010 Dec; 6(6):634-40. PubMed ID: 21361127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aloe-emodin loaded solid lipid nanoparticles: formulation design and in vitro anti-cancer study.
    Chen R; Wang S; Zhang J; Chen M; Wang Y
    Drug Deliv; 2015; 22(5):666-74. PubMed ID: 24512431
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design and statistical modeling of mannose-decorated dapsone-containing nanoparticles as a strategy of targeting intestinal M-cells.
    Vieira AC; Chaves LL; Pinheiro M; Ferreira D; Sarmento B; Reis S
    Int J Nanomedicine; 2016; 11():2601-17. PubMed ID: 27354792
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Solid lipid nanoparticles for encapsulation of hydrophilic drugs by an organic solvent free double emulsion technique.
    Becker Peres L; Becker Peres L; de Araújo PHH; Sayer C
    Colloids Surf B Biointerfaces; 2016 Apr; 140():317-323. PubMed ID: 26764112
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization and formulation optimization of solid lipid nanoparticles in vitamin K1 delivery.
    Liu CH; Wu CT; Fang JY
    Drug Dev Ind Pharm; 2010 Jul; 36(7):751-61. PubMed ID: 20136495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preparation, in vitro evaluation and statistical optimization of carvedilol-loaded solid lipid nanoparticles for lymphatic absorption via oral administration.
    Shah MK; Madan P; Lin S
    Pharm Dev Technol; 2014 Jun; 19(4):475-85. PubMed ID: 23697916
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Curcumin-loaded solid lipid nanoparticles have prolonged in vitro antitumour activity, cellular uptake and improved in vivo bioavailability.
    Sun J; Bi C; Chan HM; Sun S; Zhang Q; Zheng Y
    Colloids Surf B Biointerfaces; 2013 Nov; 111():367-75. PubMed ID: 23856543
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of Isradipine Loaded Solid Lipid Nanoparticles on the Pharmacodynamic Effect in Rats.
    Thirupathi G; Swetha E; Narendar D
    Drug Res (Stuttg); 2017 Mar; 67(3):163-169. PubMed ID: 27992936
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The production and characteristics of solid lipid nanoparticles (SLNs).
    Hou D; Xie C; Huang K; Zhu C
    Biomaterials; 2003 May; 24(10):1781-5. PubMed ID: 12593960
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of Domperidone Solid Lipid Nanoparticles: In Vitro and In Vivo Characterization.
    Shazly GA; Alshehri S; Ibrahim MA; Tawfeek HM; Razik JA; Hassan YA; Shakeel F
    AAPS PharmSciTech; 2018 May; 19(4):1712-1719. PubMed ID: 29532427
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development, Optimization, and Evaluation of Carvedilol-Loaded Solid Lipid Nanoparticles for Intranasal Drug Delivery.
    Aboud HM; El Komy MH; Ali AA; El Menshawe SF; Abd Elbary A
    AAPS PharmSciTech; 2016 Dec; 17(6):1353-1365. PubMed ID: 26743643
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Formulation and evaluation of Nimodipine-loaded solid lipid nanoparticles delivered via lymphatic transport system.
    Chalikwar SS; Belgamwar VS; Talele VR; Surana SJ; Patil MU
    Colloids Surf B Biointerfaces; 2012 Sep; 97():109-16. PubMed ID: 22609590
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preparation and evaluation of novel octylmethoxycinnamate-loaded solid lipid nanoparticles.
    Liu XH; Liang XZ; Fang X; Zhang WP
    Int J Cosmet Sci; 2015 Aug; 37(4):446-53. PubMed ID: 25720757
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term stability, biocompatibility and oral delivery potential of risperidone-loaded solid lipid nanoparticles.
    Silva AC; Kumar A; Wild W; Ferreira D; Santos D; Forbes B
    Int J Pharm; 2012 Oct; 436(1-2):798-805. PubMed ID: 22867992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.